Dopamine and norepinephrine stimulate somatostatin release by median eminence fragments in vitro.
D000818:Animals; D004298:Dopamine / Q000494:pharmacology*; D018492:Dopamine Antagonists; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D066298:In Vitro Techniques; D008297:Male; D008473:Median Eminence / Q000187:drug effects* / Q000378:metabolism; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D051381:Rats; D013004:Somatostatin / Q000378:metabolism*
D018492:Dopamine Antagonists; D010868:Pimozide; D013004:Somatostatin; D004298:Dopamine; D009638:Norepinephrine; D010646:Phentolamine